Krueger Christel, Danke Christina, Pfleiderer Klaus, Schuh Wolfgang, Jäck Hans-Martin, Lochner Susanne, Gmeiner Peter, Hillen Wolfgang, Berens Christian
Department of Microbiology, Institute for Biology, Friedrich-Alexander-University Erlangen-Nuremberg, Staudtstr. 5, 91058 Erlangen, Germany.
J Gene Med. 2006 Aug;8(8):1037-47. doi: 10.1002/jgm.932.
The amount of a particular protein, and not just its presence or absence, frequently determines the outcome of a developmental process or disease progression. These dosage effects can be studied by conditionally expressing such proteins at different levels. With typical gene regulation systems like the Tet-On system, intermediate expression levels can be obtained by varying the effector concentration. However, this strategy is limited to situations in which these concentrations can be precisely controlled and, thus, not suited for animal models or gene therapy approaches. Here, we present a Tet transregulator setup that allows establishment of four levels of promoter activity largely independent of effector concentration.
A newly introduced transsilencer is combined with a reverse transactivator. As the regulators respond differentially to tetracycline derivatives, four expression levels are obtained by adding different effectors. To facilitate integration of the components, we generated versatile all-in-one vectors. Apart from a cassette expressing the transregulators and a selection marker, these vectors encode a bidirectional, regulated promoter driving expression of GFP and the gene of interest. The features of this stepwise regulation system were analyzed by transient and stable transfections of human cell lines.
We demonstrate in a variety of experimental settings that coexpression of these transregulators leads to robust stepwise regulation. Depending on the respective effectors, four expression levels are achieved with different responsive promoters, cell lines and target genes.
This system shows that a promoter can be adjusted to different activities and provides an excellent strategy to investigate protein dosage effects.
特定蛋白质的量,而非仅仅其存在与否,常常决定发育过程的结果或疾病进展。这些剂量效应可通过在不同水平上条件性表达此类蛋白质来研究。对于典型的基因调控系统,如Tet-On系统,可通过改变效应物浓度获得中间表达水平。然而,该策略仅限于能够精确控制这些浓度的情况,因此不适用于动物模型或基因治疗方法。在此,我们展示一种Tet反式调节因子设置,其可建立四个水平的启动子活性,且很大程度上独立于效应物浓度。
一种新引入的反式沉默子与一种反向反式激活因子相结合。由于这些调节因子对四环素衍生物的反应不同,通过添加不同的效应物可获得四个表达水平。为便于组件整合,我们构建了通用的一体化载体。除了一个表达反式调节因子和一个选择标记的盒式结构外,这些载体还编码一个双向、受调控的启动子,驱动绿色荧光蛋白(GFP)和目的基因的表达。通过对人细胞系进行瞬时和稳定转染,分析了这个逐步调节系统的特性。
我们在多种实验设置中证明,这些反式调节因子的共表达可导致强大的逐步调节。根据各自的效应物,使用不同的响应启动子、细胞系和靶基因可实现四个表达水平。
该系统表明启动子可被调节至不同活性,并为研究蛋白质剂量效应提供了一种出色的策略。